{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:04:19Z","timestamp":1780445059365,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Heilongjiang Provincial Health Commission scientific research project","award":["20230303010390"],"award-info":[{"award-number":["20230303010390"]}]},{"name":"Scientific research on traditional Chinese medicine of Heilongjiang Chinese Medicine Administration","award":["ZHY2024-094"],"award-info":[{"award-number":["ZHY2024-094"]}]},{"name":"Dongji academic team of Jiamusi University","award":["DJXSTD202409"],"award-info":[{"award-number":["DJXSTD202409"]}]},{"name":"Team Project of Fundamentals and Clinical Application about Cardiovascular Disease in the First Affiliated Hospital of Jiamusi University","award":["No. 202302"],"award-info":[{"award-number":["No. 202302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47002-x","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:46:18Z","timestamp":1775904378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acteoside attenuates myocardial ischemia reperfusion injury by inhibiting the NLRP3 inflammasome activity via the PI3K\/Akt signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Linlin","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"1","key":"47002_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","volume":"5","author":"G Heusch","year":"2024","unstructured":"Heusch, G. Myocardial ischemia\/reperfusion: Translational pathophysiology of ischemic heart disease. Med 5 (1), 10\u201331. https:\/\/doi.org\/10.1016\/j.medj.2023.12.007 (2024).","journal-title":"Med"},{"issue":"20","key":"47002_CR2","doi-asserted-by":"publisher","first-page":"e2300161","DOI":"10.1002\/adhm.202300161","volume":"12","author":"X Li","year":"2023","unstructured":"Li, X. et al. Nanomedicine-based therapeutics for myocardial ischemic\/reperfusion injury. Adv. Healthc. Mater. 12 (20), e2300161. https:\/\/doi.org\/10.1002\/adhm.202300161 (2023).","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"47002_CR3","doi-asserted-by":"publisher","first-page":"e022352","DOI":"10.1161\/JAHA.122.022352","volume":"12","author":"P Zhabyeyev","year":"2023","unstructured":"Zhabyeyev, P. et al. Loss of PI3K\u03b1 mediates protection from myocardial ischemia-reperfusion injury linked to preserved mitochondrial function. J. Am. Heart Assoc. 12 (12), e022352. https:\/\/doi.org\/10.1161\/JAHA.122.022352 (2023).","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"47002_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","volume":"35","author":"Q Xiang","year":"2024","unstructured":"Xiang, Q., Yi, X., Zhu, X. H., Wei, X. & Jiang, D. S. Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol. Metab. 35 (3), 219\u2013234. https:\/\/doi.org\/10.1016\/j.tem.2023.10.010 (2024).","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"47002_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","volume":"15","author":"S Toldo","year":"2018","unstructured":"Toldo, S. & Abbate, A. The NLRP3 inflammasome in acute myocardial infarction. Nat. Rev. Cardiol. 15 (4), 203\u2013214. https:\/\/doi.org\/10.1038\/nrcardio.2017.161 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"47002_CR6","doi-asserted-by":"publisher","first-page":"156260","DOI":"10.1016\/j.phymed.2024.156260","volume":"136","author":"XH Wei","year":"2025","unstructured":"Wei, X. H. et al. Salvianolic acid B alleviated myocardial ischemia-reperfusion injury via modulating SIRT3-mediated crosstalk between mitochondrial ROS and NLRP3. Phytomedicine 136, 156260. https:\/\/doi.org\/10.1016\/j.phymed.2024.156260 (2025).","journal-title":"Phytomedicine"},{"key":"47002_CR7","doi-asserted-by":"publisher","first-page":"103244","DOI":"10.1016\/j.redox.2024.103244","volume":"75","author":"Y Duan","year":"2024","unstructured":"Duan, Y. et al. A detrimental role of endothelial S1PR2 in cardiac ischemia-reperfusion injury via modulating mitochondrial dysfunction, NLRP3 inflammasome activation, and pyroptosis. Redox Biol. 75, 103244. https:\/\/doi.org\/10.1016\/j.redox.2024.103244 (2024).","journal-title":"Redox Biol."},{"issue":"1","key":"47002_CR8","doi-asserted-by":"publisher","first-page":"e13410","DOI":"10.1111\/imr.13410","volume":"329","author":"S Gupta","year":"2025","unstructured":"Gupta, S., Cassel, S. L., Sutterwala, F. S. & Dagvadorj, J. Regulation of the NLRP3 inflammasome by autophagy and mitophagy. Immunol. Rev. 329 (1), e13410. https:\/\/doi.org\/10.1111\/imr.13410 (2025).","journal-title":"Immunol. Rev."},{"key":"47002_CR9","doi-asserted-by":"publisher","first-page":"174699","DOI":"10.1016\/j.ejphar.2021.174699","volume":"916","author":"RA Khan","year":"2022","unstructured":"Khan, R. A. et al. Anticancer effects of acteoside: Mechanistic insights and therapeutic status. Eur. J. Pharmacol. 916, 174699. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174699 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"47002_CR10","doi-asserted-by":"publisher","first-page":"121829","DOI":"10.1016\/j.indcrop.2025.121829","volume":"236","author":"N Cardullo","year":"2025","unstructured":"Cardullo, N. et al. Recovery of verbascoside from lantana camara pruning waste for development of phytosomes with antioxidant and hypoglycemic properties. Ind. Crops Prod. 236, 121829. https:\/\/doi.org\/10.1016\/j.indcrop.2025.121829 (2025).","journal-title":"Ind. Crops Prod."},{"key":"47002_CR11","doi-asserted-by":"publisher","first-page":"113296","DOI":"10.1016\/j.biopha.2022.113296","volume":"153","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y., Ren, Q. & Wu, L. The pharmacokinetic property and pharmacological activity of acteoside: A review. Biomed. Pharmacother. 153, 113296. https:\/\/doi.org\/10.1016\/j.biopha.2022.113296 (2022).","journal-title":"Biomed. Pharmacother"},{"issue":"19","key":"47002_CR12","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.1021\/jf9028333","volume":"57","author":"CH Chen","year":"2009","unstructured":"Chen, C. H., Song, T. Y., Liang, Y. C. & Hu, L. Acteoside and 6-O-acetylacteoside downregulate cell adhesion molecules induced by IL-1beta through inhibition of ERK and JNK in human vascular endothelial cells. J. Agric. Food Chem. 57 (19), 8852\u20138859. https:\/\/doi.org\/10.1021\/jf9028333 (2009).","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"47002_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/mmr.2025.13442","volume":"31","author":"J Li","year":"2025","unstructured":"Li, J. et al. Preconditioning with acteoside ameliorates myocardial ischemia-reperfusion injury by targeting HSP90AA1 and the PI3K\/Akt signaling pathway. Mol. Med. Rep. 31 (3), 77. https:\/\/doi.org\/10.3892\/mmr.2025.13442 (2025).","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"47002_CR14","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1007\/s12035-023-03418-4","volume":"60","author":"JY Kim","year":"2023","unstructured":"Kim, J. Y., Hwang, M., Choi, N. Y. & Koh, S. H. Inhibition of the NLRP3 inflammasome activation\/assembly through the activation of the PI3K pathway by naloxone protects neural stem cells from ischemic condition. Mol. Neurobiol. 60 (9), 5330\u20135342. https:\/\/doi.org\/10.1007\/s12035-023-03418-4 (2023).","journal-title":"Mol. Neurobiol."},{"issue":"19","key":"47002_CR15","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/1873-3468.14175","volume":"595","author":"X Guo","year":"2021","unstructured":"Guo, X. et al. AKT controls NLRP3 inflammasome activation by inducing DDX3X phosphorylation. FEBS Lett. 595 (19), 2447\u20132462. https:\/\/doi.org\/10.1002\/1873-3468.14175 (2021).","journal-title":"FEBS Lett."},{"issue":"6","key":"47002_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s12265-021-10125-9","volume":"14","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. The protective mechanism of dexmedetomidine in regulating Atg14L-Beclin1-Vps34 complex against myocardial ischemia-reperfusion injury. J. Cardiovasc. Transl Res. 14 (6), 1063\u20131074. https:\/\/doi.org\/10.1007\/s12265-021-10125-9 (2021).","journal-title":"J. Cardiovasc. Transl Res."},{"issue":"1","key":"47002_CR17","doi-asserted-by":"publisher","first-page":"16644","DOI":"10.1038\/s41598-020-73643-7","volume":"10","author":"VS Sajja","year":"2020","unstructured":"Sajja, V. S. et al. Pulmonary injury risk curves and behavioral changes from blast overpressure exposures of varying frequency and intensity in rats. Sci. Rep. 10 (1), 16644. https:\/\/doi.org\/10.1038\/s41598-020-73643-7 (2020).","journal-title":"Sci. Rep."},{"issue":"3","key":"47002_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cardiores.2004.01.028","volume":"62","author":"H Sun","year":"2004","unstructured":"Sun, H., Oudit, G. Y., Ramirez, R. J., Costantini, D. & Backx, P. H. The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik,slow currents. Cardiovasc. Res. 62 (3), 509\u2013520. https:\/\/doi.org\/10.1016\/j.cardiores.2004.01.028 (2004).","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"47002_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.55730\/1300-0152.2695","volume":"48","author":"M \u00d6ztu\u011f","year":"2024","unstructured":"\u00d6ztu\u011f, M., Kilin\u00e7, E., \u00d6ztu\u011f Durer, Z. A. & Balo\u011flu, E. Proteomic investigation of acute and chronic hypoxia\/reoxygenation responsive proteins and pathways in H9C2 cardiomyoblasts. Turk. J. Biol. 48 (3), 192\u2013202. https:\/\/doi.org\/10.55730\/1300-0152.2695 (2024).","journal-title":"Turk. J. Biol."},{"issue":"1","key":"47002_CR20","doi-asserted-by":"publisher","first-page":"16601","DOI":"10.1038\/s41598-020-73608-w","volume":"10","author":"NJ Pluijmert","year":"2020","unstructured":"Pluijmert, N. J., Bart, C. I., Bax, W. H., Quax, P. H. A. & Atsma, D. E. Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice. Sci. Rep. 10 (1), 16601. https:\/\/doi.org\/10.1038\/s41598-020-73608-w (2020).","journal-title":"Sci. Rep."},{"issue":"2","key":"47002_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/a-1739-9351","volume":"43","author":"N Schanze","year":"2023","unstructured":"Schanze, N., Hamad, M. A., N\u00fchrenberg, T. G., Bode, C. & Duerschmied, D. Platelets in myocardial ischemia\/reperfusion injury. Hamostaseologie 43 (2), 110\u2013121. https:\/\/doi.org\/10.1055\/a-1739-9351 (2023).","journal-title":"Hamostaseologie"},{"issue":"15","key":"47002_CR22","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1080\/14656566.2020.1787987","volume":"21","author":"A Rout","year":"2020","unstructured":"Rout, A., Tantry, U. S., Novakovic, M., Sukhi, A. & Gurbel, P. A. Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction. Expert Opin. Pharmacother. 21 (15), 1851\u20131865. https:\/\/doi.org\/10.1080\/14656566.2020.1787987 (2020).","journal-title":"Expert Opin. Pharmacother"},{"key":"47002_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/978-3-319-55330-6_31","volume":"982","author":"B Shin","year":"2017","unstructured":"Shin, B., Cowan, D. B., Emani, S. M., Del Nido, P. J. & McCully, J. D. Mitochondrial transplantation in myocardial ischemia and reperfusion injury. Adv. Exp. Med. Biol. 982, 595\u2013619. https:\/\/doi.org\/10.1007\/978-3-319-55330-6_31 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"47002_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-pharmtox-010715-103335","volume":"57","author":"EJ Lesnefsky","year":"2017","unstructured":"Lesnefsky, E. J., Chen, Q., Tandler, B. & Hoppel, C. L. Mitochondrial dysfunction and myocardial ischemia-reperfusion: Implications for novel therapies. Annu. Rev. Pharmacol. Toxicol. 57, 535\u2013565. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010715-103335 (2017).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"47002_CR25","doi-asserted-by":"publisher","first-page":"e934255","DOI":"10.12659\/MSM.934255","volume":"28","author":"S Shen","year":"2022","unstructured":"Shen, S., Wang, Z., Sun, H. & Ma, L. Role of NLRP3 inflammasome in myocardial ischemia-reperfusion injury and ventricular remodeling. Med. Sci. Monit. 28, e934255. https:\/\/doi.org\/10.12659\/MSM.934255 (2022).","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"47002_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/1061186X.2022.2085728","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. The NLRP3 inflammasome: Contributions to inflammation-related diseases. Cell. Mol. Biol. Lett. 28 (1), 51. https:\/\/doi.org\/10.1080\/1061186X.2022.2085728 (2023).","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"47002_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/jcmm.16281","volume":"25","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. Neuregulin-1 alleviate oxidative stress and mitigate inflammation by suppressing NOX4 and NLRP3\/caspase-1 in myocardial ischaemia-reperfusion injury. J. Cell. Mol. Med. 25 (3), 1783\u20131795. https:\/\/doi.org\/10.1111\/jcmm.16281 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"47002_CR28","doi-asserted-by":"publisher","first-page":"5271251","DOI":"10.1155\/2016\/5271251","volume":"2016","author":"R Mastrocola","year":"2016","unstructured":"Mastrocola, R. et al. Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia\/reperfusion injury by activation of RISK and mitochondrial pathways. Oxid. Med. Cell. Longev. 2016, 5271251. https:\/\/doi.org\/10.1155\/2016\/5271251 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"24","key":"47002_CR29","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1182\/blood-2017-05-782102","volume":"130","author":"S Nazir","year":"2017","unstructured":"Nazir, S. et al. Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition. Blood 130 (24), 2664\u20132677. https:\/\/doi.org\/10.1182\/blood-2017-05-782102 (2017).","journal-title":"Blood"},{"key":"47002_CR30","doi-asserted-by":"publisher","first-page":"174856","DOI":"10.1016\/j.ejphar.2022.174856","volume":"920","author":"Z Lei","year":"2022","unstructured":"Lei, Z. et al. Piperazine ferulate protects against cardiac ischemia\/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis. Eur. J. Pharmacol. 920, 174856. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174856 (2022).","journal-title":"Eur. J. Pharmacol."},{"issue":"22","key":"47002_CR31","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.jacc.2024.02.056","volume":"83","author":"FGP Welt","year":"2024","unstructured":"Welt, F. G. P. et al. Reperfusion injury in patients with acute myocardial infarction: JACC scientific statement. J. Am. Coll. Cardiol. 83 (22), 2196\u20132213. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.056 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"47002_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet, M. et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc. Med. 33 (6), 357\u2013366. https:\/\/doi.org\/10.1016\/j.tcm.2022.02.005 (2023).","journal-title":"Trends Cardiovasc. Med."},{"key":"47002_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110714","author":"RM Deng","year":"2023","unstructured":"Deng, R. M. & Zhou, J. The role of PI3K\/AKT signaling pathway in myocardial ischemia-reperfusion injury. Int. Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2023.110714 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"47002_CR34","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/jcmm.12501","volume":"19","author":"D Sun","year":"2015","unstructured":"Sun, D. et al. Oncostatin M (OSM) protects against cardiac ischaemia\/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity. J. Cell. Mol. Med. 19 (6), 1296\u20131307. https:\/\/doi.org\/10.1111\/jcmm.12501 (2015).","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"47002_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/kjm2.12627","volume":"39","author":"L Sun","year":"2023","unstructured":"Sun, L., Lu, W. X., Li, H., Feng, D. Y. & Nie, J. X. Total saponins of Aralia elata (Miq.) Seem. alleviate myocardial ischemia-reperfusion injury by promoting NLRP3-inflammasome inactivation via PI3K\/Akt signaling. Kaohsiung J. Med. Sci. 39 (3), 290\u2013301. https:\/\/doi.org\/10.1002\/kjm2.12627 (2023).","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"19","key":"47002_CR36","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3390\/diagnostics14192132","volume":"14","author":"A Asiri","year":"2024","unstructured":"Asiri, A., Al Qarni, A. & Bakillah, A. The interlinking metabolic association between type 2 diabetes mellitus and cancer: Molecular mechanisms and therapeutic insights. Diagnostics (Basel). 14 (19), 2132. https:\/\/doi.org\/10.3390\/diagnostics14192132 (2024).","journal-title":"Diagnostics (Basel)"},{"key":"47002_CR37","doi-asserted-by":"publisher","first-page":"981206","DOI":"10.3389\/fphar.2022.981206","volume":"13","author":"M Li","year":"2022","unstructured":"Li, M. et al. QishenYiqi dripping pill protects against myocardial ischemia\/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology. Front. Pharmacol. 13, 981206. https:\/\/doi.org\/10.3389\/fphar.2022.981206 (2022).","journal-title":"Front. Pharmacol."},{"key":"47002_CR38","doi-asserted-by":"publisher","first-page":"1281607","DOI":"10.3389\/fimmu.2023.1281607","volume":"14","author":"F Bornancin","year":"2023","unstructured":"Bornancin, F. & Dekker, C. A phospho-harmonic orchestra plays the NLRP3 score. Front. Immunol. 14, 1281607. https:\/\/doi.org\/10.3389\/fimmu.2023.1281607 (2023).","journal-title":"Front. Immunol."},{"issue":"6","key":"47002_CR39","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/10742484211027405","volume":"26","author":"SV Popov","year":"2021","unstructured":"Popov, S. V. et al. The role of pyroptosis in ischemic and reperfusion injury of the heart. J. Cardiovasc. Pharmacol. Ther. 26 (6), 562\u2013574. https:\/\/doi.org\/10.1177\/10742484211027405 (2021).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"1","key":"47002_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.apsb.2022.08.007","volume":"13","author":"P Yanpiset","year":"2023","unstructured":"Yanpiset, P. et al. Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies. Acta Pharm. Sin B. 13 (1), 29\u201353. https:\/\/doi.org\/10.1016\/j.apsb.2022.08.007 (2023).","journal-title":"Acta Pharm. Sin B"},{"issue":"20","key":"47002_CR41","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.3390\/cells11203271","volume":"11","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Research progress on the role of pyroptosis in myocardial ischemia-reperfusion injury. Cells 11 (20), 3271. https:\/\/doi.org\/10.3390\/cells11203271 (2022).","journal-title":"Cells"},{"issue":"4","key":"47002_CR42","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q. & Kitsis, R. N. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol. Rev. 99 (4), 1765\u20131817. https:\/\/doi.org\/10.1152\/physrev.00022.2018 (2019).","journal-title":"Physiol. Rev."},{"issue":"3","key":"47002_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/FJC.0000000000000694","volume":"74","author":"A Rauf","year":"2019","unstructured":"Rauf, A., Shah, M., Yellon, D. M. & Davidson, S. M. Role of caspase 1 in ischemia\/reperfusion injury of the myocardium. J. Cardiovasc. Pharmacol. 74 (3), 194\u2013200. https:\/\/doi.org\/10.1097\/FJC.0000000000000694 (2019).","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"9","key":"47002_CR44","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/antiox10091445","volume":"10","author":"PF Hsieh","year":"2021","unstructured":"Hsieh, P. F., Yu, C. C., Chu, P. M. & Hsieh, P. L. Verbascoside protects gingival cells against high glucose-induced oxidative stress via PKC\/HMGB1\/RAGE\/NF\u03baB pathway. Antioxid. (Basel). 10 (9), 1445. https:\/\/doi.org\/10.3390\/antiox10091445 (2021).","journal-title":"Antioxid. (Basel)"},{"issue":"6","key":"47002_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.7555\/JBR.36.20220123","volume":"36","author":"NV Naryzhnaya","year":"2022","unstructured":"Naryzhnaya, N. V. et al. Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy. J. Biomed. Res. 36 (6), 375\u2013389. https:\/\/doi.org\/10.7555\/JBR.36.20220123 (2022).","journal-title":"J. Biomed. Res."},{"issue":"1","key":"47002_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12872-025-04762-0","volume":"25","author":"J Li","year":"2025","unstructured":"Li, J. et al. The cardioprotective effects of acteoside in myocardial ischemia reperfusion injury and the underlying mechanism. BMC Cardiovasc. Disord. 25 (1), 329. https:\/\/doi.org\/10.1186\/s12872-025-04762-0 (2025).","journal-title":"BMC Cardiovasc. Disord"},{"issue":"5","key":"47002_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/ph16050739","volume":"16","author":"SA Syed Abd Halim","year":"2023","unstructured":"Syed Abd Halim, S. A., Abd Rashid, N., Woon, C. K. & Abdul Jalil, N. A. Natural products targeting PI3K\/AKT in myocardial ischemic reperfusion injury: A scoping review. Pharmaceuticals (Basel). 16 (5), 739. https:\/\/doi.org\/10.3390\/ph16050739 (2023).","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"47002_CR48","doi-asserted-by":"publisher","first-page":"102747","DOI":"10.1016\/j.omtn.2025.102747","volume":"36","author":"XR Ma","year":"2025","unstructured":"Ma, X. R., Yan, T. M., Pan, Y. & Jiang, Z. H. Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia\/reperfusion injury. Mol. Ther. Nucleic Acids. 36 (4), 102747. https:\/\/doi.org\/10.1016\/j.omtn.2025.102747 (2025).","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47002-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:31:59Z","timestamp":1780443119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47002-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47002"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47002-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study protocol was approved by the Institutional Animal Care and Use Committee of the Basic Medical College, Jiamusi University (protocol code JDJCYXY20240031 and 2024-09-26 date of approval).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"17068"}}